Some fundamental drivers such as market cap or CVS Health enterprice value can be analyzed from historical prospective to project value of the company into the future. Some investors analyze CVS Health valuation indicators such as Revenue Per Employee of 704.7 K or Average Assets of 93.1 B to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of CVS Health future value. Financial Statement Analysis is much more than just reviewing and breaking down CVS Health prevalent accounting reports in order to predict its past. Macroaxis encourages investors to analyze financial statement over time for various trends across multiple indicators and accounts to determine whether CVS Health is a good buy for the upcoming year. Check also Trending Equities.
Enterprise Value (or EV) is usually referred to as CVS Health theoretical takeover price. In the event of an acquisition, an acquirer would have to take on CVS Health debt, but would also pocket its cash. Enterprise Value is more accurate representation of CVS Health value then its market capitalization because it takes into account all of CVS Health Corporation existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.
Market capitalization (or market cap) is the total value of the shares outstanding of CVS Health Corporation. It is equal to CVS Health current share price times the number of CVS Health outstanding shares. Represents the product of Total Shares (Basic) ; Adjusted Share Price and Entity Share Factor.
Did you try this?
Run Money Flow Index Now
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Check also Trending Equities. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.